ERS/EACTS statement on the management of malignant pleural effusions
Malignant pleural effusions (MPE) are a common pathology, treated by respiratory
physicians and thoracic surgeons alike. In recent years, several well-designed randomized …
physicians and thoracic surgeons alike. In recent years, several well-designed randomized …
European Respiratory Society statement on thoracic ultrasound
Thoracic ultrasound is increasingly considered to be an essential tool for the pulmonologist.
It is used in diverse clinical scenarios, including as an adjunct to clinical decision making for …
It is used in diverse clinical scenarios, including as an adjunct to clinical decision making for …
British Thoracic Society guideline for pleural disease
Conservative management can be considered for the treatment of minimally symptomatic
(ie, no significant pain or breathlessness and no physiological compromise) or …
(ie, no significant pain or breathlessness and no physiological compromise) or …
Malignant pleural effusion: presentation, diagnosis, and management
S Gayen - The American Journal of Medicine, 2022 - Elsevier
Malignant pleural effusions are common in patients with cancer. Most malignant pleural
effusions are secondary to metastases to the pleura, most often from lung or breast cancer …
effusions are secondary to metastases to the pleura, most often from lung or breast cancer …
Interventions for the management of malignant pleural effusions: a network meta‐analysis
Background Malignant pleural effusion (MPE) is a common problem for people with cancer
as a result of malignant infiltration of the pleura. It is usually associated with considerable …
as a result of malignant infiltration of the pleura. It is usually associated with considerable …
Malignant pleural effusion: from bench to bedside
Malignant pleural effusion (MPE) is a common but serious condition that is related with poor
quality of life, morbidity and mortality. Its incidence and associated healthcare costs are …
quality of life, morbidity and mortality. Its incidence and associated healthcare costs are …
Efficacy and cost of video-assisted thoracoscopic partial pleurectomy versus talc pleurodesis in patients with malignant pleural mesothelioma (MesoVATS): an open …
Background Malignant pleural mesothelioma incidence continues to rise, with few available
evidence-based therapeutic options. Results of previous non-randomised studies suggested …
evidence-based therapeutic options. Results of previous non-randomised studies suggested …
Effect of thoracoscopic talc poudrage vs talc slurry via chest tube on pleurodesis failure rate among patients with malignant pleural effusions: a randomized clinical trial
R Bhatnagar, HEG Piotrowska, M Laskawiec-Szkonter… - Jama, 2020 - jamanetwork.com
Importance Malignant pleural effusion (MPE) is challenging to manage. Talc pleurodesis is a
common and effective treatment. There are no reliable data, however, regarding the optimal …
common and effective treatment. There are no reliable data, however, regarding the optimal …
British thoracic Society Clinical Statement on pleural procedures
A total of 21 659 pleural aspirations or drain insertions were conducted in England in
2019/2020 with a combined cost of£ 13.4 million. 1 There are now a variety of different …
2019/2020 with a combined cost of£ 13.4 million. 1 There are now a variety of different …
Malignant pleural effusion: from diagnostics to therapeutics
R Asciak, NM Rahman - Clinics in chest medicine, 2018 - chestmed.theclinics.com
Malignant pleural effusion (MPE) is one of the commonest causes of an exudative pleural
effusion, and its incidence is increasing with increasing cancer prevalence and as more …
effusion, and its incidence is increasing with increasing cancer prevalence and as more …